NeuroScientific Biopharmaceuticals Ltd is an Australia-based pharmaceutical company. The Company develops peptide-based drugs that target neurodegenerative conditions. The Company’s product portfolio consists of EmtinB, 15mS.A, and other Emtin peptides. EmtinB is the Company’s lead therapeutic peptide candidate targeting Alzheimer's disease. 15mS.A. is a diagnostic peptide foe early-stage Alzheimer’s disease. Other Emtin peptides include EmtinAc, EmtinAn, and EmtinBn that demonstrates similar therapeutic properties as EmtinB.